Albina J E, Mills C D, Henry W L, Caldwell M D
Department of Surgery, Rhode Island Hospital, Providence 02903.
J Immunol. 1990 May 15;144(10):3877-80.
Arginine can be metabolized by inflammatory cells through at least two pathways. One is an oxidative l-arginine deiminase (OAD) that results in the formation of citrulline and reactive nitrogen intermediates. The other is arginase, which determines the production of ornithine and urea. The temporal expression of these pathways in an experimental wound model (s.c. implanted polyvinyl alcohol sponges in the rat) was investigated by examining the concentrations of amino acids and of nitrite in fluids obtained from the sponges 6 h to 15 day after implantation. These analyses revealed two distinct periods during which the arginine concentration in the fluids was markedly below plasma levels. During the early period (less than 3 days after sponge implantation) wound fluid contained more citrulline and nitrite than at any other time, suggesting OAD activity. In contrast, ornithine accumulated in the fluids during the late decrease in arginine concentration that extended beyond day 3, during which time the wound fluid also contained a high arginase activity. This time-dependent expression of different pathways of arginine metabolism in wounds was confirmed in sponge cultures containing [guanido-14C]-l-arginine. Cells contained in sponges harvested less than 48 h after implantation metabolized labeled arginine mainly to labeled citrulline, whereas labeled urea was produced during culture of sponges harvested after this time. The low arginine content of wound fluid did not appear to be rate limiting for the expression of OAD in late sponges because no OAD activity was evidenced when 4 mM arginine was added to the cultures. These results indicate that the OAD pathway is expressed in this model predominantly during the early, polymorphonuclear leukocyte-predominant, phase of repair. At this time, the reactive nitrogen intermediates resulting from the metabolism of arginine may mediate some of the events characteristic of early inflammation, including microbiostasis, vasodilation, and inhibition/reversal of platelet aggregation. In turn, the late suppression of this pathway and the catabolism of arginine through arginase may promote macrophage function within wounds.
精氨酸可通过至少两条途径被炎症细胞代谢。一条途径是氧化型L-精氨酸脱亚氨酶(OAD),它会导致瓜氨酸和活性氮中间体的形成。另一条途径是精氨酸酶,它决定鸟氨酸和尿素的生成。通过检测植入后6小时至15天从海绵中获取的液体中氨基酸和亚硝酸盐的浓度,研究了这些途径在实验性伤口模型(大鼠皮下植入聚乙烯醇海绵)中的时间表达情况。这些分析揭示了两个不同的时期,在此期间液体中的精氨酸浓度明显低于血浆水平。在早期(海绵植入后不到3天),伤口液体中含有的瓜氨酸和亚硝酸盐比其他任何时候都多,这表明存在OAD活性。相反,在精氨酸浓度在第3天之后开始的后期下降过程中,鸟氨酸在液体中积累,在此期间伤口液体中也含有高活性的精氨酸酶。在含有[胍基-14C]-L-精氨酸的海绵培养物中证实了伤口中精氨酸代谢不同途径的这种时间依赖性表达。植入后不到48小时收获的海绵中的细胞将标记的精氨酸主要代谢为标记的瓜氨酸,而在此时间之后收获的海绵在培养过程中产生标记的尿素。伤口液体中低含量的精氨酸似乎并不是后期海绵中OAD表达的限速因素,因为当向培养物中添加4 mM精氨酸时未发现OAD活性。这些结果表明,在该模型中,OAD途径主要在早期以多形核白细胞为主的修复阶段表达。此时,精氨酸代谢产生的活性氮中间体可能介导早期炎症的一些特征性事件,包括微生物抑制、血管舒张以及血小板聚集的抑制/逆转。反过来,该途径的后期抑制以及通过精氨酸酶对精氨酸的分解代谢可能会促进伤口内巨噬细胞的功能。